• 1. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 2. Aggregation-induced emission enhancement of carbon quantum dots and applications in light emitting devices
  Rongyan Guo,Tao Li,Shuie Shi J. Mater. Chem. C, 2019,7, 5148-5154
• 3. An integrated droplet-digital microfluidic system for on-demand droplet creation, mixing, incubation, and sorting?
  Lab Chip, 2019,19, 524-535
• 4. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 5. Aggregation dynamics, structure, and mechanical properties of bigels
  L. Di Michele,D. Fiocco,F. Varrato,E. Eiser,G. Foffi Soft Matter, 2014,10, 3633-3648

5-Pyrimidinecarboxylic Acid, 2,4,6-Trimethyl-, Methyl Ester (CAS No. 108169-16-0)

The compound 5-Pyrimidinecarboxylic Acid, 2,4,6-Trimethyl-, Methyl Ester (CAS No. 108169-16-0) is a structurally unique organic compound with significant potential in various chemical and pharmaceutical applications. This compound belongs to the class of pyrimidine derivatives, which are well-known for their diverse biological activities and roles in natural products and synthetic molecules. The methyl ester functional group attached to the pyrimidine ring adds versatility to its chemical properties, making it a valuable intermediate in organic synthesis.

Recent studies have highlighted the importance of pyrimidine derivatives in drug discovery, particularly in the development of anticancer agents. The 2,4,6-trimethyl substitution pattern on the pyrimidine ring is intriguing due to its potential to modulate the compound's pharmacokinetic properties and bioavailability. Researchers have explored the synthesis of this compound through various routes, including nucleophilic aromatic substitution and condensation reactions. These methods have been optimized to enhance yield and purity, ensuring its suitability for large-scale production.

The methyl ester group in this compound plays a crucial role in its chemical reactivity and stability. It has been shown to improve solubility in organic solvents, making it easier to handle during purification and subsequent reactions. Moreover, the methyl ester can be readily converted into other functional groups, such as carboxylic acids or amides, enabling further diversification of its applications.

In terms of biological activity, 5-Pyrimidinecarboxylic Acid, 2,4,6-Trimethyl-, Methyl Ester has demonstrated promising results in preliminary assays targeting enzyme inhibition and cell proliferation. For instance, recent research has shown that this compound exhibits selective inhibition against certain kinases involved in cancer cell signaling pathways. This finding underscores its potential as a lead compound for developing novel anticancer therapies.

Another area of interest is the use of this compound as a building block in medicinal chemistry. Its pyrimidine core serves as a scaffold for constructing more complex molecules with enhanced bioactivity. For example, researchers have successfully incorporated this compound into macrocyclic structures that exhibit potent antimicrobial activity against multidrug-resistant bacteria.

From a synthetic perspective, the preparation of 5-Pyrimidinecarboxylic Acid, 2,4,6-Trimethyl-, Methyl Ester involves a series of well-established organic reactions. The starting material is typically a substituted pyrimidine derivative that undergoes methylation under controlled conditions to introduce the methyl ester group. This process is often followed by purification techniques such as column chromatography or recrystallization to ensure high purity.

Furthermore, computational studies have been conducted to predict the physicochemical properties and toxicity profile of this compound. These studies reveal that it has favorable pharmacokinetic properties, including moderate solubility and permeability across biological membranes. Such insights are critical for designing preclinical studies and optimizing drug delivery systems.

In conclusion, 5-Pyrimidinecarboxylic Acid, 2,4,6-Trimethyl-, Methyl Ester (CAS No. 108169-16-0) is a versatile compound with significant potential in pharmaceutical research and organic synthesis. Its unique structure and functional groups make it an attractive candidate for developing novel therapeutic agents and advanced materials.

• 62359-65-3(5-Pyrimidinecarboxylic acid, 4-formyl-2-methyl-, ethyl ester)
• 108397-75-7(trimethylpyrimidine-5-carboxylic acid)
• 74356-36-8(2,4-Dimethylpyrimidine-5-carboxylic acid)
• 157335-94-9(methyl 4-methylpyrimidine-5-carboxylate)
• 110960-73-1(Ethyl 4-methylpyrimidine-5-carboxylate)
• 832090-49-0(5-Pyrimidinecarboxylic acid, 4-ethyl-2,6-dimethyl-, methyl ester)
• 70733-12-9(5-Pyrimidinecarboxylicacid, 4-methyl-2-phenyl-, ethyl ester)
• 2226-86-0(2,4-Dimethyl-pyrimidine-5-carboxylic Acid Ethyl Ester)
• 832090-45-6(5-Pyrimidinecarboxylic acid, 4,6-dimethyl-2-phenyl-, methyl ester)
• 832090-44-5(Methyl 4,6-dimethylpyrimidine-5-carboxylate)